[1] | Chu SY, Weng CY . Introduction to genetic/rare disease and the application of genetic counseling. Hu Li Za Zhi, 2017,64(5):11-17. | [1] | 褚思义, 翁纯英 . 遗传/罕见病简介及遗传咨询的应用. 护理杂志, 2017,64(5):11-17. | [2] | Darrow JJ . Luxturna: FDA documents reveal the value of a costly gene therapy. Drug Discov Today, 2019,24(4):949-954. | [3] | Han X, Ni W . Cost-Effectiveness analysis of glybera for the treatment of lipoprotein lipase deficiency. Value Health, 2015,18(7):A756. | [4] | Schimmer J, Breazzano S . Investor outlook: rising from the ashes; GSK's European approval of strimvelis for ADA-SCID. Hum Gene Ther Clin Dev, 2016,27(2):57-61. | [5] | Gupta SK, Shukla P . Gene editing for cell engineering: trends and applications. Crit Rev Biotechnol, 2017,37(5):672-684. | [6] | Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A, Takeda S . Homologous recombination and non- homologous end-joining pathways of DNA double- strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J, 1998,17(18):5497-5508. | [7] | Lieber MR, Ma Y, Pannicke U, Schwarz K . Mechanism and regulation of human non-homologous DNA end- joining. Nat Rev Mol Cell Bio, 2003,4(9):712-720. | [8] | Joung JK, Sander JD . TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Bio, 2012,14(1):49-55. | [9] | Sander JD, Joung JK . CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol, 2014,32(4):347-355. | [10] | Komor AC, Badran AH, Liu DR . CRISPR-Based technologies for the manipulation of eukaryotic genomes. Cell, 2017,168(1-2):20-36. | [11] | Marcaida MJ, Prieto J, Redondo P . Crystal structure of I-DmoI in complex with its target DNA provides new insights into meganuclease engineering. Proc Natl Acad Sci USA, 2008,105(44):16888-16893. | [12] | Smith J, Grizot S, Arnould S, Duclert A, Epinat JC, Chames P, Prieto J, Redondo P, Blanco FJ, Bravo J, Montoya G, Paques F, Duchateau P . A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Res, 2006,34(22):e149. | [13] | Silva G, Poirot L, Galetto R, Smith J, Montoya G, Duchateau P, Paques F . Meganucleases and other tools for targeted genome engineering: Perspectives and challenges for gene therapy. Curr Gene Ther, 2011,11(1):11-27. | [14] | Wang L, Smith J, Breton C, Clark P, Zhang J, Ying L, Che Y, Lape J, Bell P, Calcedo R, Buza EL, Saveliev A, Bartsevich |
[1] |
Zhong Bian, Dongping Cao, Wenshu Zhuang, Shuwei Zhang, Qiaoquan Liu, Lin Zhang.
Revelation of rice molecular design breeding: the blend of tradition and modernity
[J]. Hereditas(Beijing), 2023, 45(9): 718-740.
|
[2] |
Bingzheng Wang, Chao Zhang, Jiali Zhang, Jin Sun.
Conditional editing of the Drosophila melanogaster genome using single transcripts expressing Cas9 and sgRNA
[J]. Hereditas(Beijing), 2023, 45(7): 593-601.
|
[3] |
Xiaojun Zhang, Kun Xu, Juncen Shen, Lu Mu, Hongrun Qian, Jieyu Cui, Baoxia Ma, Zhilong Chen, Zhiying Zhang, Zehui Wei.
A CRISPR/Cas9-Gal4BD donor adapting system for enhancing homology-directed repair
[J]. Hereditas(Beijing), 2022, 44(8): 708-719.
|
[4] |
Yuting Han, Bowen Xu, Yutong Li, Xinyi Lu, Xizhi Dong, Yuhao Qiu, Qinyun Che, Ruibao Zhu, Li Zheng, Xiaochen Li, Xu Si, Jianquan Ni.
The cutting edge of gene regulation approaches in model organism Drosophila
[J]. Hereditas(Beijing), 2022, 44(1): 3-14.
|
[5] |
Dingwei Peng, Ruiqiang Li, Wu Zeng, Min Wang, Xuan Shi, Jianhua Zeng, Xiaohong Liu, Yaoshen Chen, Zuyong He.
Editing the cystine knot motif of MSTN enhances muscle development of Liang Guang Small Spotted pigs
[J]. Hereditas(Beijing), 2021, 43(3): 261-270.
|
[6] |
Guoling Li, Shanxin Yang, Zhenfang Wu, Xianwei Zhang.
Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals
[J]. Hereditas(Beijing), 2020, 42(7): 641-656.
|
[7] |
Yingnan Chen, Jing Lu.
Application of CRISPR/Cas9 mediated gene editing in trees
[J]. Hereditas(Beijing), 2020, 42(7): 657-668.
|
[8] |
Lianchao Tang, Feng Gu.
Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM
[J]. Hereditas(Beijing), 2020, 42(3): 236-249.
|
[9] |
Junxia Cao, Youliang Wang, Zhengxu Wang.
Advances in precise regulation of CRISPR/Cas9 gene editing technology
[J]. Hereditas(Beijing), 2020, 42(12): 1168-1177.
|
[10] |
Liwen Bao, Yiye Zhou, Fanyi Zeng.
Advances in gene therapy for β-thalassemia and hemophilia based on the CRISPR/Cas9 technology
[J]. Hereditas(Beijing), 2020, 42(10): 949-964.
|
[11] |
Qianqian Zhang,Xuan Shang,Wanying Lin,Xiangmin Xu.
Effect of genetic modifiers on the clinical severity of β-thalassemia
[J]. Hereditas(Beijing), 2019, 41(8): 669-676.
|
[12] |
Hao Ou,Guoling Li,Haoqiang Wang,Guangyan Huang,Gengyuan Cai,Zicong Li,Zhenfang Wu,Xianwei Zhang.
MEK inhibitor PD0325901 significantly boosts ssODN-mediated HDR efficiency in porcine fetal fibroblasts
[J]. Hereditas(Beijing), 2019, 41(4): 327-336.
|
[13] |
Yunxiao Ren, Rudan Xiao, Xiaomin Lou, Xiangdong Fang.
Research advance and application in the gene therapy of gene editing technologies
[J]. Hereditas(Beijing), 2019, 41(1): 18-27.
|
[14] |
Gaowei Xin, Xixun Hu, Kejian Wang, Xingchun Wang.
Cas9 protein variant VQR recognizes NGAC protospacer adjacent motif in rice
[J]. Hereditas(Beijing), 2018, 40(12): 1112-1119.
|
[15] |
Yiou Chen, Ying Bao, Huazheng Ma, Zongyi Yi, Zhuo Zhou, Wensheng Wei.
Gene editing technology and its research progress in China
[J]. Hereditas(Beijing), 2018, 40(10): 900-915.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
|
|
|